本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Bioventus Inc.

7.27
-0.1700-2.28%
盤後7.270.00000.00%18:18 EDT
成交量:112.12萬
成交額:812.70萬
市值:6.01億
市盈率:262.53
高:7.44
開:7.44
低:7.09
收:7.44
52周最高:14.38
52周最低:5.81
股本:8,267.90萬
流通股本:4,322.04萬
量比:2.28
換手率:2.59%
股息:- -
股息率:- -
每股收益(TTM):0.0277
每股收益(LYR):-0.5196
淨資產收益率:1.39%
總資產收益率:3.64%
市淨率:3.73
市盈率(LYR):-13.99

資料載入中...

2024/11/01

SEC問詢函

Form CORRESP - Correspondence
2024/10/04

重要事件披露

Form 8-K - Current report
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/19

重要事件披露

Form 8-K - Current report
2024/07/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]